You may opt out of marketing communications at any time by following the unsubscribe instructions in our emails or by contacting [email protected]
Frozen and thawed peptide solutions may appear normal but have undergone irreversible structural changes
A review of potential options for therapeutic intervention
48 Similarly, among obese individuals without diabetes, semaglutide use was shown to increase the risk of developing GI adverse events by 1.59 times compared with the control group
The GLP-1 market, projected to hit $100B by 2030 (Goldman Sachs, 2025), is driven by 11% obesity rates in India (World Obesity Federation, 2025) and global demand outpacing supply (Mint, 2025)
Although combining GLP-1 agonists and bariatric surgery shows promise, there are challenges in determining the optimal timing, dosing, and patient selection for this approach